Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) Research & Development (2016 - 2025)

Merit Medical Systems' Research & Development history spans 16 years, with the latest figure at $26.5 million for Q4 2025.

  • For Q4 2025, Research & Development rose 5.35% year-over-year to $26.5 million; the TTM value through Dec 2025 reached $97.4 million, up 11.3%, while the annual FY2025 figure was $97.4 million, 11.3% up from the prior year.
  • Research & Development for Q4 2025 was $26.5 million at Merit Medical Systems, up from $24.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $26.5 million in Q4 2025 and bottomed at $16.3 million in Q1 2021.
  • The 5-year median for Research & Development is $20.4 million (2021), against an average of $20.7 million.
  • The largest annual shift saw Research & Development skyrocketed 34.84% in 2021 before it increased 0.15% in 2022.
  • A 5-year view of Research & Development shows it stood at $20.4 million in 2021, then grew by 0.15% to $20.4 million in 2022, then increased by 5.89% to $21.6 million in 2023, then rose by 16.43% to $25.2 million in 2024, then increased by 5.35% to $26.5 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Research & Development are $26.5 million (Q4 2025), $24.0 million (Q3 2025), and $24.4 million (Q2 2025).